Inventor

Zhenming AN

Inventor

Overview

3→

Patents

2025–2026

Patent span

Human necessities

Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes23%

C07KPeptides23%

G01NInvestigating or analysing materials by determining their chemical or physical properties23%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture8%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%

PatentTitleYear

12,540,345Composition comprising aflibercept and a variant thereof, and related methods and uses2026 12,415,853Antibody against claudin 18A2 and use thereof2025 12,240,888Composition comprising aflibercept and a variant thereof, and related methods and uses2025

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2025–2026Patents assigned to QILU PHARMACEUTICAL CO LTD (3)· patent assignee history

2025–2026Based in CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
QILU PHARMACEUTICAL CO LTD	3	2025–2026

Locations

Location	Patents	Span
CN	3	2025–2026